allogeneic human dental pulp stem cell

Cell therapyexperimental

Clinical trial activity

4 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2014 (NCT02523651)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    Tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • allogeneic human dental pulp stem cell

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05924373Phase 2Jun 30, 2023Capital Medical University, Peking University
NCT04983225Phase 1Jul 31, 2021Capital Medical University, Peking University
NCT04336254Phase 1/Phase 2 (Phase 2)Apr 6, 2020Wuhan University
NCT02523651Phase 1/Phase 2 (Phase 2)Dec 1, 2014Capital Medical University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Capital Medical UniversityAcademic/Hospital3122014
Peking UniversityAcademic/Hospital2222021
Wuhan UniversityAcademic/Hospital1112020
3 organizations
Page 1 / 1